These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 7542354)

  • 1. [Porphyria cutanea tarda accompanying hepatitis C].
    Yamazaki Y; Kiyosawa K
    Nihon Rinsho; 1995 Jun; 53(6):1468-73. PubMed ID: 7542354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C and porphyria cutanea tarda.
    English JC; Peake MF; Becker LE
    Cutis; 1996 Jun; 57(6):404-8. PubMed ID: 8804842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis C virus infection and porphyria cutanea tarda].
    López Morante A; Sáez-Royuela F; Martín Lorente JL; Yuguero del Moral L; Ojeda Giménez C
    Gastroenterol Hepatol; 1995 Jan; 18(1):7-10. PubMed ID: 7621273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acquired characteristics of porphyria cutanea tarda in patients infected with hepatitis C virus].
    Wolff C; Stella AM; Armas R; Parraguez A; Silva H; Batlle AM
    Rev Med Chil; 1998 Mar; 126(3):245-50. PubMed ID: 9674292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of hepatitis C virus in porphyria cutanea tarda hepatopathy].
    Quecedo L; Costa J; Enríquez de Salamanca R
    Med Clin (Barc); 1996 Mar; 106(9):321-4. PubMed ID: 8667696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus in patients with porphyria cutanea tarda: relationship to HCV-genotypes.
    Rivanera D; Lilli D; Griso D; Macrì A; Mancini C
    New Microbiol; 1998 Oct; 21(4):329-34. PubMed ID: 9812313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection.
    Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE
    Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haem biosynthesis and human porphyria cutanea tarda: effects of alcohol intake.
    Mukerji SK
    Indian J Exp Biol; 2000 Jul; 38(7):635-42. PubMed ID: 11215304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis C, hemochromatosis and porphyria cutanea tarda].
    Teubner A; Richter M; Schuppan D; Köstler E; Stölzel U
    Dtsch Med Wochenschr; 2006 Mar; 131(13):691-5. PubMed ID: 16555178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of porphyria cutanea tarda and hepatitis C virus].
    Martín-Vivaldi Martínez R; Espinosa Aguilar MD; Sánchez Sanchéz-Vizcaíno J; Quintero Fuentes D; Nogueras López F; López de Hierro Ruiz M
    Rev Esp Enferm Dig; 1996 Mar; 88(3):213-6. PubMed ID: 8645516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The frequency of viral hepatitis C in patients with porphyria cutanea tarda].
    Malina L; Arenberger P; Kracíková J
    Cas Lek Cesk; 1994 Oct; 133(19):599-601. PubMed ID: 7525065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Porphyria cutanea tarda and hepatitis C virus].
    Emri G; Tornai I; Pósán E; Seszták T; Varga V; Horkay I
    Orv Hetil; 2001 Nov; 142(47):2635-9. PubMed ID: 11778362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porphyria cutanea tarda and hepatitis C viral infection. A clinical and virologic study.
    Cribier B; Petiau P; Keller F; Schmitt C; Vetter D; Heid E; Grosshans E
    Arch Dermatol; 1995 Jul; 131(7):801-4. PubMed ID: 7611796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Porphyria cutanea tarda--new views on its pathogenesis and therapy].
    Falkiewicz B; Dabrowska E; Jabłońska-Kaszewska I
    Wiad Lek; 1997; 50(4-6):106-11. PubMed ID: 9381711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study.
    Stölzel U; Schuppan D; Tillmann HL; Manns MP; Tannapfel A; Doss MO; Zimmer T; Köstler E
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):43-7. PubMed ID: 11929046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
    Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Falkiewicz B
    Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of hepatitis C virus infection in Japanese patients with porphyria cutanea tarda.
    Kondo M; Horie Y; Okano J; Kitamura A; Maeda N; Kawasaki H; Mishiro S; Yamamoto S; Itou T; Saeki S; Tanaka S; Okamoto H
    Hepatology; 1997 Jul; 26(1):246. PubMed ID: 9214482
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatocellular carcinoma associated to porphyria cutanea tarda and hepatitis C virus infection without cirrhosis].
    Moreno FJ; Santoyo J; Bondía JA; Suárez MA; Jiménez M; Fernández JL; Conde M; Marín R; Ribeiro M; Peláez JM; de la Fuente A
    Rev Esp Enferm Dig; 1998 Jan; 90(1):48-50. PubMed ID: 9558946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda.
    Lamoril J; Andant C; Bogard C; Puy H; Gouya L; Pawlotsky JM; Da Silva V; Soulé JC; Deybach JC; Nordmann Y
    Hepatology; 1998 Mar; 27(3):848-52. PubMed ID: 9500716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Porphyria cutanea tarda and hepatitis C virus infection].
    Held E; Petersen CS
    Ugeskr Laeger; 1997 Feb; 159(9):1284-6. PubMed ID: 9072876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.